TargetedDeepSeq_Sample_14
Homo sapiens
On-target C-to-T editing frequencies of different treatment distinguished by barcode: 1:fig3b-edfig6c_293FT_tBE-VLP3-2.5μl_PRR5L_2; 2:fig3b-edfig6c_293FT_tBE-VLP3-5μl_PRR5L_2; 3:fig3b-edfig6c_293FT_tBE-VLP3-10μl_PRR5L_2; 4:fig3b-edfig6c_293FT_tBE-VLP3-20μl_PRR5L_2; 5:edfig7a_Hela_tBE-VLP3-2.5μl_PRR5L_2; 6:edfig7a_Hela_tBE-VLP3-5μl_PRR5L_2; 7:edfig7a_Hela_tBE-VLP3-10μl_PRR5L_2; 8:edfig7a_Hela_tBE-VLP3-20μl_PRR5L_2; 9:edfig7b_U2OS_tBE-VLP3-2.5μl_PRR5L_2; 10:edfig7b_U2OS_tBE-VLP3-5μl_PRR5L_2; 11:edfig7b_U2OS_tBE-VLP3-10μl_PRR5L_2; 12:edfig7b_U2OS_tBE-VLP3-20μl_PRR5L_2
isolate
DNA
age
NA
biomaterial_provider
Li Yang
collection_date
not collected
geo_loc_name
not applicable
sex
not applicable
tissue
NA
cell_line
293FT cells, U2OS cells, Hela cells
treatment
1:fig3b-edfig6c_293FT_tBE-VLP3-2.5μl_PRR5L_2; 2:fig3b-edfig6c_293FT_tBE-VLP3-5μl_PRR5L_2; 3:fig3b-edfig6c_293FT_tBE-VLP3-10μl_PRR5L_2; 4:fig3b-edfig6c_293FT_tBE-VLP3-20μl_PRR5L_2; 5:edfig7a_Hela_tBE-VLP3-2.5μl_PRR5L_2; 6:edfig7a_Hela_tBE-VLP3-5μl_PRR5L_2; 7:edfig7a_Hela_tBE-VLP3-10μl_PRR5L_2; 8:edfig7a_Hela_tBE-VLP3-20μl_PRR5L_2; 9:edfig7b_U2OS_tBE-VLP3-2.5μl_PRR5L_2; 10:edfig7b_U2OS_tBE-VLP3-5μl_PRR5L_2; 11:edfig7b_U2OS_tBE-VLP3-10μl_PRR5L_2; 12:edfig7b_U2OS_tBE-VLP3-20μl_PRR5L_2
BioSampleModel
Human